Invivyd (IVVD) EBT Margin Growth (1y) (2025)

Invivyd (IVVD) EBT Margin Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - -
2 Nanobiotix 1,914.07 Bn 1,914.01 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 469.68 Bn 464.89 Bn 1.35 Bn 1,526.00
5 Vertex Pharmaceuticals 122.76 Bn 115.51 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 70.40 Bn 61.65 Bn 3.31 Bn -683.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.88 Bn 50.69 Bn 1.41 Bn 452.00
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 1,939.00
10 Invivyd 104.14 Mn -122.55 Mn 16.07 Mn 6,291.00

Historic Data

Download Data
DateValue
Dec 31, 2025 6,291.00
Sep 30, 2025 58,446.00
Jun 30, 2025 206,360.00